| HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g |
84 |
| Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment |
74 |
| The emerging functions and roles of circular RNAs in cancer |
61 |
| Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer |
57 |
| Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship |
55 |
| The role of STAT3 in leading the crosstalk between human cancers and the immune system |
46 |
| Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review |
45 |
| The emerging role of exosome-derived non-coding RNAs in cancer biology |
45 |
| Apigenin: A dietary flavonoid with diverse anticancer properties |
44 |
| Precision diagnosis and treatment of liver cancer in China |
43 |
| Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer |
42 |
| Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype |
42 |
| Circular RNAs (circRNAs) in cancer |
42 |
| Long noncoding RNAs in cancer cells |
42 |
| Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis |
42 |
| A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus |
40 |
| Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer |
37 |
| The long noncoding RNA LUCAT1 promotes tumorigenesis by controlling ubiquitination and stability of DNA methyltransferase 1 in esophageal squamous cell carcinoma |
37 |
| Circular RNA ciRS-7 accelerates ESCC progression through acting as a miR-876-5p sponge to enhance MAGE-A family expression |
37 |
| Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer |
36 |
| YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma |
36 |
| LncRNA CDKN2B-AS1 promotes tumor growth and metastasis of human hepatocellular carcinoma by targeting let-7c-5p/NAP1L1 axis |
36 |
| Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer |
36 |
| Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy |
33 |
| Long non-coding RNA SNHG15 interacts with and stabilizes transcription factor Slug and promotes colon cancer progression |
33 |
| Emerging landscape of circular RNAs in lung cancer |
31 |
| Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells |
29 |
| Fatty acid oxidation: An emerging facet of metabolic transformation in cancer |
28 |
| Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BUD in gastric cancer |
28 |
| CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis |
28 |
| The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China |
28 |
| Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1-and ABCG2-overexpressing cancer cells |
27 |
| LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis |
27 |
| hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307 |
26 |
| Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8 |
26 |
| Milk exosomes - Natural nanoparticles for siRNA delivery |
26 |
| Interplay between the lung microbiome and lung cancer |
26 |
| Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/beta-catenin signaling pathway |
26 |
| Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma |
26 |
| Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets |
25 |
| A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA |
25 |
| Long non-coding RNA FGF13-AS1 inhibits glycolysis and sternness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop |
24 |
| The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR |
24 |
| Reactive oxygen species and cancer: A complex interaction |
24 |
| MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes |
24 |
| Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U |
23 |
| HOX transcript antisense RNA (HOTAIR) in cancer |
23 |
| CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer |
23 |
| miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer |
22 |
| Targetable long non-coding RNAs in cancer treatments |
21 |